Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Engy F. Madyan"'
Autor:
Hussein Sabit, Borros Arneth, Shaimaa Abdel-Ghany, Engy F. Madyan, Ashraf H. Ghaleb, Periasamy Selvaraj, Dong M. Shin, Ramireddy Bommireddy, Ahmed Elhashash
Publikováno v:
Cells, Vol 13, Iss 19, p 1666 (2024)
Liver cancer represents a substantial global health challenge, contributing significantly to worldwide morbidity and mortality. It has long been understood that tumors are not composed solely of cancerous cells, but also include a variety of normal c
Externí odkaz:
https://doaj.org/article/6bc01286a85846648b557cddd5100424
Autor:
Osama A. M. Said, Emre Cevik, Suriya Rehman, Sara Raslan, Ayhan Bozkurt, Aly Shamseddin, Shaimaa Abdel-Ghany, Mehmet Şenel, Huseyin Tombuloglu, Engy F Madyan, Hussein Sabit
Publikováno v:
3 Biotech. 10
Breast cancer is a group of diseases in which cells divide out of controlled, typically resulting in a mass. Erlotinib is targeted cancer drug which functions as an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase. It is used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9feb1060ed6a6272e758a93e756243c0
https://doi.org/10.1007/s13205-020-02391-2
https://doi.org/10.1007/s13205-020-02391-2
Autor:
Shaimaa, Abdel-Ghany, Sara, Raslan, Huseyin, Tombuloglu, Aly, Shamseddin, Emre, Cevik, Osama A, Said, Engy F, Madyan, Mehmet, Senel, Ayhan, Bozkurt, Suriya, Rehman, Hussein, Sabit
Publikováno v:
3 Biotech
Breast cancer is a group of diseases in which cells divide out of controlled, typically resulting in a mass. Erlotinib is targeted cancer drug which functions as an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase. It is used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9658cefb71f50c8cf9efea178846f90e
https://pubmed.ncbi.nlm.nih.gov/32904337
https://pubmed.ncbi.nlm.nih.gov/32904337